Image
Practice Point
Neoadjuvant therapy – Role of imaging before and after therapy
In patients with breast cancer who are treated with neoadjuvant systemic therapy, use imaging prior to the commencement of therapy and at the completion of therapy, to assist with surgical planning. The type of imaging (ultrasound or MRI) will be dependent on the histopathology of the breast lesion. In addition, use localisation techniques in the breast lesion and in any biopsy-proven positive lymph nodes before therapy is commenced.
How this guidance was developed
No evidence-based source recommendation relevant to the current Australian healthcare context was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. Specification of the type of imaging to be used was avoided as this should be individualised to the patient as judged by the radiologist.
Neoadjuvant therapy – Role of imaging before and after therapy
Practice Point
In patients with breast cancer who are treated with neoadjuvant systemic therapy, use imaging prior to the commencement of therapy and at the completion of therapy, to assist with surgical planning. The type of imaging (ultrasound or MRI) will be dependent on the histopathology of the breast lesion. In addition, use localisation techniques in the breast lesion and in any biopsy-proven positive lymph nodes before therapy is commenced.
Principles in action
Safe and quality care
Image
Care coordination
No evidence-based source recommendation relevant to the current Australian healthcare context was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. Specification of the type of imaging to be used was avoided as this should be individualised to the patient as judged by the radiologist.